(Q48147188)

9 February 2018

title

Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. (English)

1 reference

9 February 2018

0 references

0 references

1 reference

8

Hudson MM

1 reference

9 February 2018

author name string

Lustig RH

1

1 reference

9 February 2018

Rose SR

2

1 reference

9 February 2018

Burghen GA

3

1 reference

9 February 2018

Velasquez-Mieyer P

4

1 reference

9 February 2018

Broome DC

5

1 reference

9 February 2018

Smith K

6

1 reference

9 February 2018

Li H

7

1 reference

9 February 2018

Heideman RL

9

1 reference

9 February 2018

Kun LE

10

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 August 1999

1 reference

9 February 2018

The Journal of Pediatrics

published in

1 reference

9 February 2018

volume

135

1 reference

9 February 2018

page(s)

162-168

1 reference

9 February 2018

issue

2 Pt 1

1 reference

9 February 2018

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

1 reference

Long-term follow-up of children with craniopharyngioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

Children with craniopharyngioma. Early growth failure and rapid postoperative weight gain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

Hyperphagia, Rage, and Dementia Accompanying a Ventromedial Hypothalamic Neoplasm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

An hypothesis on the aetiology of obesity: dysfunction of the central nervous system as a primary cause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

Neural pathways involved in the hypothalamic integration of autonomic responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

Craniopharyngioma: endocrine sequelae of treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

Increases in Plasma Insulin Levels in Response to Electrical Stimulation of the Dorsal Motor Nucleus of the Vagus Nerve*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

Involvement of the cholinergic system in insulin and glucagon oversecretion of genetic preobesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

Octreotide: a long-acting inhibitor of endogenous hormone secretion for human metabolic investigations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

Evaluation of growth hormone release in children using arginine and l-dopa in combination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

Transcription factor abnormalities as a cause of beta cell dysfunction in diabetes: a hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

Acute Hyperinsulinemia and Its Reversal by Vagotomy after Lesions of the Ventromedial Hypothalamus in Anesthetized Rats*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

Effect of vagotomy on serum insulin in rats with paraventricular or ventromedial hypothalamic lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

The effects of subdiaphragmatic vagotomy in rats with ventromedial hypothalamic obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

Truncal vagotomy in hypothalamic obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

Dose-dependent effect of octreotide on insulin secretion after OGTT in obesity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

Effects of the somatostatin analog, octreotide, on glucose metabolism and insulin sensitivity in insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

Clinical studies with dexfenfluramine: from past to future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

Sibutramine: a novel new agent for obesity treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

Long-term octreotide treatment reduced hyperinsulinemia, excess body weight and skin lesions in severe obesity with acanthosis nigricans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

Characterization of somatostatin binding sites in isolated rat adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

Inhibition of growth hormone-stimulated lipolysis by somatostatin, insulin, and insulin-like growth factors (somatomedins) in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

Localization of sequences for the basal and insulin-like growth factor-I inducible activity of the fatty acid synthase promoter in 3T3-L1 fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

Somatostatin decreases food intake of rats and baboons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

Peripherally administered somatostatin reduces feeding by a vagal mediated mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

Weight relative to height before and during growth hormone therapy in prepubertal children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

Insulin normalization as an approach to the pharmacological treatment of obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2899%2970017-X

10.1016/S0022-3476(99)70017-X

7 January 2021

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

10431109

1 reference

9 February 2018